|
In-hospital clinical outcomes
|
|
All-stroke
|
17 (2.8)
|
24 (3.2)
|
0.778
|
16 (3.4)
|
11 (2.3)
|
0.435
|
|
New permanent pacemaker implantation*
|
40/553 (7.5)
|
66/677 (9.7)
|
0.170
|
33/415 (8.0)
|
42/426 (9.9)
|
0.332
|
|
Major vascular complication (VARC-3)
|
39 (6.4)
|
66 (8.8)
|
0.122
|
29 (6.1)
|
45 (9.5)
|
0.069
|
|
Bleeding type 3 and 4 (VARC-3)
|
26 (4.3)
|
33 (4.4)
|
0.999
|
18 (3.8)
|
17 (3.6)
|
0.999
|
|
Cardiac structural complication (VARC-3)
|
5 (0.8)
|
12 (1.6)
|
0.298
|
4 (0.8)
|
5 (1.1)
|
0.999
|
|
Myocardial infarction
|
0 (0.0)
|
3 (0.4)
|
0.326
|
0 (0.0)
|
2 (0.4)
|
0.479
|
|
Coronary obstruction requiring PCI
|
1 (0.2)
|
3 (0.4)
|
0.768
|
1 (0.2)
|
2 (0.4)
|
0.999
|
|
AKIN 2/3/4
|
18 (3.0)
|
23 (3.1)
|
0.999
|
15 (3.2)
|
15 (3.2)
|
0.999
|
|
In-hospital mortality
|
7 (1.2)
|
7 (0.9)
|
0.904
|
5 (1.1)
|
4 (0.8)
|
0.999
|
|
30-day clinical outcomes
|
Neo2 n=598**
|
Ultra n=734**
|
p-value
|
Neo2 n=464**
|
Ultra n=465**
|
p-value
|
|
All-cause mortality
|
11 (1.8)
|
18 (2.5)
|
0.566
|
8 (1.7)
|
11 (2.4)
|
0.646
|
|
All-stroke
|
18 (3.0)
|
23 (3.1)
|
0.999
|
16 (3.4)
|
11 (2.4)
|
0.435
|
|
Cardiovascular rehospitalisation
|
5 (0.8)
|
7 (1.0)
|
0.999
|
5 (1.1)
|
3 (0.6)
|
0.723
|
|
New pacemaker implantation*
|
40/522 (7.7)
|
70/664 (10.5)
|
0.090
|
33/406 (8.1)
|
43/419 (10.3)
|
0.289
|
|
Repeat procedure
|
0 (0.0)
|
1 (0.1)
|
0.999
|
0 (0.0)
|
0 (0.0)
|
–
|
|
Data are median [interquartile range] or n (%). *Excluding patients with pacemaker at baseline. **Patients with available follow-up at 30 days in the entire population 1,332/1,356 and in the matched population 929/944. AKIN: Acute Kidney Injury Network classifcation; CHF: congestive heart failure; PCI: percutaneous coronary intervention; THV: transcatheter heart valve
|
